Current role
Adam Crystal
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Adam Crystal
The proxy statement of Tango Therapeutics, Inc. reports total compensation of $1,721,080 for Adam Crystal in fiscal 2025, including a base salary of $588,638. Disclosed compensation is on record for 3 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Tango Therapeutics, Inc. (TNGX)
Proxy statement
CurrentStart not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Tango Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Malte Peters CEO, Board Member
- Malte Peters, M.D. CEO
- Barbara Weber Chairman
- Barbara Weber, M.D. Chairman
- Matthew Gall CFO
- Jessica Newcomb Chief Accounting Officer
- James B. Avery Board Member
- John Ketchum Board Member
- Lesley Ann Calhoun Board Member
- Lesley Calhoun Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Tango Therapeutics, Inc. (TNGX) | M.D., Ph.D. President of Research and Development | $588,638 | $1,721,080 |
| 2024 | Tango Therapeutics, Inc. (TNGX) | M.D., Ph.D. President of Research and Development | $569,250 | $3,777,318 |
| 2023 | Tango Therapeutics, Inc. (TNGX) | M.D., Ph.D. President of Research and Development | $454,808 | $3,110,646 |
Recent activity
No call appearances or filed executive changes recorded yet.